Europe
Researchers have found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
This was on top of Syncona’s previously announced Series C investment in Freeline of $40 million, with another $80 million in new capital.
Clinical-stage biotechnology company BioNTech announced a private investment of $250 million today, led by Temasek and other investors.
Salt water gargle is a time-tested way to alleviate sore-throat pain. It can help clear stuffy sinuses. But, is it effective against the symptoms of COVID-19?
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
DBV Technologies, located just outside Paris, announced it is cutting jobs while it awaits news from the U.S. Food and Drug Administration (FDA) about its application for Viaskin Peanut.
Despite the bleak challenges brought on by COVID-19, Bill Sibold, executive vice president of Sanofi Genzyme, is optimistic that some of the greatest discoveries in medicine and treating various diseases are within the grasp of the pharmaceutical industry.
Novartis, Novartis Hellas and Alcon Inc. have agreed to pay a total of more than $346 million to settle bribery charges under the Foreign Corrupt Practices Act (FCPA), which is a U.S. anti-bribery law.
According to a brief report by Reuters, the drug company plans to hold meetings with staff representatives tomorrow and Monday of next week to describe a restructuring plan, according to four sources familiar with the matter.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.
PRESS RELEASES